81
Views
13
CrossRef citations to date
0
Altmetric
Brief Report

Levels of paraoxonase, an index of antioxidant defense, in patients with active sarcoidosis

, , , , , , & show all
Pages 1651-1657 | Accepted 17 Apr 2008, Published online: 02 May 2008
 

ABSTRACT

Objective: Oxidative mechanisms are currently discussed as playing a crucial role in the genesis of inflammatory lung diseases. We aimed to evaluate the oxidant–antioxidant balance in the pathogenesis and activity of sarcoidosis and to search if the change in the level of PON can be taken as an activity marker.

Methods: 26 active sarcoidosis subjects aged 41.3 ± 12.9 years, 37 inactive subjects aged 39.6 ± 11.7 years and 48 control subjects aged 48.9 ± 2.5 years were recruited in our study. Malondialdehyde (MDA), paraoxonase1 (PON1) and oxidized low density lipoprotein (oxLDL) levels in serum were analyzed by spectrophotometric, kinetic, and ELISA methods, respectively.

Results: PON1 levels were significantly lower in the active disease state than both the inactive form and control groups. MDA levels were significantly higher in active sarcoidosis than both the inactive disease and control groups, and oxLDL levels were significantly higher in the active disease group than the inactive group and control group. The level of PON1 in the inactive disease group is not significantly different from the control group while the oxLDL and MDA levels of inactive group is significantly higher than the control group (p < 0.001). There was a negative correlation between the PON1 activities and MDA values in both active and inactive groups (p = 0.008).

Conclusion: Oxidative stress increases in sarcoidosis might be due to both increase in lipid peroxidation and decrease in antioxidant status (PON1) and the relationship between oxidative status and the activation of the disease should be discussed by comparing the previously known activation criteria.

Acknowledgments

Declaration of interest: There was no pharmaceutical company involvement with this article. The authors declare that they have no competing interests with respect to the contents of this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.